For instance, PKM2-deficient xenograft tumor models established in vivo did not exhibit restricted tumor growth, and similarly, PKM2 knockdown had no significant inhibitory effect on TNBC (Cortés-Cros et al., 2013; Israelsen et al., 2013). The gene discussed is PKM; the disease is neoplasm.